HIF mediated and DNA damage independent histone H2AX phosphorylation in chronic hypoxia

Abstract The histone variant 2AX (H2AX) is phosphorylated at Serine 139 by the PI3K-like kinase family members ATM, ATR and DNA-PK. Genotoxic stress, such as tumor radio- and chemotherapy, is considered to be the main inducer of phosphorylated H2AX (γH2AX), which forms distinct foci at sites of DNA damage where DNA repair factors accumulate. γH2AX accumulation under severe hypoxic/anoxic (0.02% oxygen) conditions has recently been reported to follow replication fork stalling in the absence of detectable DNA damage. In this study, we found HIF-dependent accumulation of γH2AX in several cancer cell lines and mouse embryonic fibroblasts exposed to physiologically relevant chronic hypoxia (0.2% oxygen), which did not induce detectable levels of DNA strand breaks. The hypoxic accumulation of γH2AX was delayed by the RNAi-mediated knockdown of HIF-1α or HIF-2α and further decreased when both HIF-αs were absent. Conversely, basal phosphorylation of H2AX was increased in cells with constitutively stabilized HIF-2α. These results suggest that both HIF-1 and HIF-2 are involved in γH2AX accumulation by tumor hypoxia, which might increase a cancer cell’s capacity to repair DNA damage, contributing to tumor therapy resistance.

[1]  W. Mckenna,et al.  Targeting radiation-resistant hypoxic tumour cells through ATR inhibition , 2012, British Journal of Cancer.

[2]  G. Kristiansen,et al.  Non-canonical HIF-2α function drives autonomous breast cancer cell growth via an AREG–EGFR/ErbB4 autocrine loop , 2012, Oncogene.

[3]  D. Biard,et al.  A DNA-dependent stress response involving DNA-PK occurs in hypoxic cells and contributes to cellular adaptation to hypoxia , 2011, Journal of Cell Science.

[4]  M. Dewhirst,et al.  Molecular Imaging of Hypoxia , 2011, The Journal of Nuclear Medicine.

[5]  James B. Mitchell,et al.  Low-field magnetic resonance imaging to visualize chronic and cycling hypoxia in tumor-bearing mice. , 2010, Cancer research.

[6]  Lionel Flamant,et al.  Anti-apoptotic role of HIF-1 and AP-1 in paclitaxel exposed breast cancer cells under hypoxia , 2010, Molecular Cancer.

[7]  S. Lowe,et al.  HIF-1 antagonizes p53-mediated apoptosis through a secreted neuronal tyrosinase , 2010, Nature.

[8]  Xiao-dan Liu,et al.  DNA-PKcs plays a dominant role in the regulation of H2AX phosphorylation in response to DNA damage and cell cycle progression , 2010, BMC Molecular Biology.

[9]  A. Nussenzweig,et al.  Histone H2AX is integral to hypoxia-driven neovascularization , 2009, Nature Medicine.

[10]  K. Khanna,et al.  Involvement of Exo1b in DNA damage-induced apoptosis , 2009, Nucleic acids research.

[11]  P. Beard,et al.  H2AX Is Required for Cell Cycle Arrest via the p53/p21 Pathway , 2009, Molecular and Cellular Biology.

[12]  D. Guidolin,et al.  Transcriptional regulation of hypoxia-inducible factor 1alpha by HIPK2 suggests a novel mechanism to restrain tumor growth. , 2009, Biochimica et biophysica acta.

[13]  R. Wenger,et al.  Impaired DNA double-strand break repair contributes to chemoresistance in HIF-1 alpha-deficient mouse embryonic fibroblasts. , 2008, Carcinogenesis.

[14]  M. Koike,et al.  Tissue-specific DNA-PK-dependent H2AX phosphorylation and gamma-H2AX elimination after X-irradiation in vivo. , 2008, Biochemical and biophysical research communications.

[15]  A. Giaccia,et al.  Hypoxic Conditions Atm Activation and Signaling Under , 2008 .

[16]  Xin Wang,et al.  Effects of lentivirus-mediated HIF-1α knockdown on hypoxia-related cisplatin resistance and their dependence on p53 status in fibrosarcoma cells , 2008, Cancer Gene Therapy.

[17]  F. de Longueville,et al.  Hypoxia induces protection against etoposide-induced apoptosis: molecular profiling of changes in gene expression and transcription factor activity , 2008, Molecular Cancer.

[18]  Richard P. Hill,et al.  Hypoxia and metabolism: Hypoxia, DNA repair and genetic instability , 2008, Nature Reviews Cancer.

[19]  Tae Funakoshi,et al.  2-methoxyestradiol inhibits hypoxia-inducible factor-1{alpha} and suppresses growth of lesions in a mouse model of endometriosis. , 2008, The American journal of pathology.

[20]  F. Bunz,et al.  ATM and ATR: Components of an Integrated Circuit , 2007, Cell cycle.

[21]  T. Osaki,et al.  The involvement of hypoxia‐inducible factor‐1α in the susceptibility to γ‐rays and chemotherapeutic drugs of oral squamous cell carcinoma cells , 2007 .

[22]  V. Grégoire,et al.  Preconditioning of the tumor vasculature and tumor cells by intermittent hypoxia: implications for anticancer therapies. , 2006, Cancer research.

[23]  Q. Peng,et al.  Induction of hypoxia-inducible factor-1α overexpression by cobalt chloride enhances cellular resistance to photodynamic therapy , 2006 .

[24]  G. Semenza,et al.  Heterozygous HIF‐1α deficiency impairs carotid body‐mediated systemic responses and reactive oxygen species generation in mice exposed to intermittent hypoxia , 2006, The Journal of physiology.

[25]  Roland H Wenger,et al.  Increased Prolyl 4-Hydroxylase Domain Proteins Compensate for Decreased Oxygen Levels , 2006, Journal of Biological Chemistry.

[26]  S. Fesik,et al.  Hypoxia-Inducible Factor-1 Inhibition in Combination with Temozolomide Treatment Exhibits Robust Antitumor Efficacy In vivo , 2006, Clinical Cancer Research.

[27]  Manuela Milani,et al.  Hypoxia-Inducible Factor-1α Expression Predicts a Poor Response to Primary Chemoendocrine Therapy and Disease-Free Survival in Primary Human Breast Cancer , 2006, Clinical Cancer Research.

[28]  V. Natale,et al.  H2AX phosphorylation within the G1 phase after UV irradiation depends on nucleotide excision repair and not DNA double-strand breaks. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[29]  R. Nagatomi,et al.  Knockdown of hypoxia‐inducible factor‐1α by siRNA inhibits C2C12 myoblast differentiation , 2006, Journal of cellular biochemistry.

[30]  J. Pouysségur,et al.  Hypoxia signalling in cancer and approaches to enforce tumour regression , 2006, Nature.

[31]  David J. Chen,et al.  DNA-PK phosphorylates histone H2AX during apoptotic DNA fragmentation in mammalian cells. , 2006, DNA repair.

[32]  R. Zhao,et al.  Knockdown of hypoxia-inducible factor-1alpha in breast carcinoma MCF-7 cells results in reduced tumor growth and increased sensitivity to methotrexate. , 2006, Biochemical and biophysical research communications.

[33]  Xianrang Song,et al.  Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1α gene , 2006, Cancer Chemotherapy and Pharmacology.

[34]  J. Erler,et al.  Reversing Hypoxic Cell Chemoresistance in Vitro Using Genetic and Small Molecule Approaches Targeting Hypoxia Inducible Factor-1 , 2006, Molecular Pharmacology.

[35]  Y. Doki,et al.  Overexpression of hypoxia-inducible factor-1 alpha in gastric adenocarcinoma , 2006, Gastric Cancer.

[36]  T. Hunter,et al.  Turning the Replication Checkpoint On and Off , 2006, Cell cycle.

[37]  G. Camenisch,et al.  Integration of Oxygen Signaling at the Consensus HRE , 2005, Science's STKE.

[38]  P. Olive,et al.  DNA-PK is responsible for enhanced phosphorylation of histone H2AX under hypertonic conditions. , 2005, DNA repair.

[39]  M. Dewhirst,et al.  Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity. , 2005, Cancer cell.

[40]  M. Dewhirst,et al.  Spatial heterogeneity and oxygen dependence of glucose consumption in R3230Ac and fibrosarcomas of the Fischer 344 rat. , 2005, Cancer research.

[41]  F. Kaper,et al.  Anoxia is necessary for tumor cell toxicity caused by a low-oxygen environment. , 2005, Cancer research.

[42]  A. Harris,et al.  Enhanced response to radiotherapy in tumours deficient in the function of hypoxia-inducible factor-1. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[43]  C. Bishop,et al.  Identification and characterization of a novel testicular germ cell‐specific gene Ggnbp1 , 2005, Molecular reproduction and development.

[44]  C. Van Waes,et al.  2-Methoxyestradiol Inhibits Hypoxia-Inducible Factor 1α, Tumor Growth, and Angiogenesis and Augments Paclitaxel Efficacy in Head and Neck Squamous Cell Carcinoma , 2004, Clinical Cancer Research.

[45]  C. Supuran,et al.  Hypoxia activates the capacity of tumor‐associated carbonic anhydrase IX to acidify extracellular pH , 2004, FEBS letters.

[46]  M. Dewhirst,et al.  Enhancement of Hypoxia-Induced Tumor Cell Death In vitro and Radiation Therapy In vivo by Use of Small Interfering RNA Targeted to Hypoxia-Inducible Factor-1α , 2004, Cancer Research.

[47]  E. Wall,et al.  The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis , 2004, Journal of Clinical Pathology.

[48]  Michel Nussenzweig,et al.  H2AX: the histone guardian of the genome. , 2004, DNA repair.

[49]  D. W. Kim,et al.  Association of DNA-dependent protein kinase with hypoxia inducible factor-1 and its implication in resistance to anticancer drugs in hypoxic tumor cells , 2004, Experimental & Molecular Medicine.

[50]  J. Brown,et al.  Exploiting tumour hypoxia in cancer treatment , 2004, Nature Reviews Cancer.

[51]  Christopher J. Schofield,et al.  Oxygen sensing by HIF hydroxylases , 2004, Nature Reviews Molecular Cell Biology.

[52]  Crispin J. Miller,et al.  Hypoxia-Mediated Down-Regulation of Bid and Bax in Tumors Occurs via Hypoxia-Inducible Factor 1-Dependent and -Independent Mechanisms and Contributes to Drug Resistance , 2004, Molecular and Cellular Biology.

[53]  P. Jeggo,et al.  ATM and DNA-PK Function Redundantly to Phosphorylate H2AX after Exposure to Ionizing Radiation , 2004, Cancer Research.

[54]  A. Giaccia,et al.  Comparison of hypoxia-induced replication arrest with hydroxyurea and aphidicolin-induced arrest. , 2003, Mutation research.

[55]  T. Ried,et al.  H2AX Haploinsufficiency Modifies Genomic Stability and Tumor Susceptibility , 2003, Cell.

[56]  R. Agarwal,et al.  Ovarian cancer: strategies for overcoming resistance to chemotherapy , 2003, Nature Reviews Cancer.

[57]  A. Giaccia,et al.  Hypoxia-Induced Gene Expression Occurs Solely through the Action of Hypoxia-Inducible Factor 1α (HIF-1α): Role of Cytoplasmic Trapping of HIF-2α , 2003, Molecular and Cellular Biology.

[58]  R. Wenger,et al.  The hypoxia-inducible factor-1α is a negative factor for tumor therapy , 2003, Oncogene.

[59]  A. Giaccia,et al.  ATR/ATM Targets Are Phosphorylated by ATR in Response to Hypoxia and ATM in Response to Reoxygenation* , 2003, The Journal of Biological Chemistry.

[60]  M. Gassmann,et al.  Regulation of the multidrug resistance transporter P‐glycoprotein in multicellular tumor spheroids by hypoxia‐inducible factor‐1 and reactive oxygen species , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[61]  L. Einhorn Chemotherapeutic and surgical strategies for germ cell tumors. , 2002, Chest surgery clinics of North America.

[62]  A. Harris,et al.  Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer. , 2002, International journal of radiation oncology, biology, physics.

[63]  R. Wenger,et al.  Cellular adaptation to hypoxia: O2‐sensing protein hydroxylases, hypoxia‐inducible transcription factors, and O2‐regulated gene expression , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[64]  Michael C. Montalto,et al.  Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. , 2002, Cancer research.

[65]  M. Gassmann,et al.  Rescue of hypoxia-inducible factor-1alpha-deficient tumor growth by wild-type cells is independent of vascular endothelial growth factor. , 2002, Cancer research.

[66]  Michel C. Nussenzweig,et al.  Genomic Instability in Mice Lacking Histone H2AX , 2002, Science.

[67]  A. Giaccia,et al.  Hypoxia Links ATR and p53 through Replication Arrest , 2002, Molecular and Cellular Biology.

[68]  N. Sang,et al.  Hypoxia-inducible Factor-1-mediated Expression of the 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3) Gene , 2002, The Journal of Biological Chemistry.

[69]  P. Thibault,et al.  Transcription Factor HIF-1 Is a Necessary Mediator of the Pasteur Effect in Mammalian Cells , 2001, Molecular and Cellular Biology.

[70]  D. Faller,et al.  Hypoxia-activated ligand HAL-1/13 is lupus autoantigen Ku80 and mediates lymphoid cell adhesion in vitro. , 2001, American journal of physiology. Cell physiology.

[71]  G. Semenza,et al.  Expression of hypoxia-inducible factor-1alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. , 2001, Cancer research.

[72]  Till Acker,et al.  Up-regulation of hypoxia-inducible factors HIF-1α and HIF-2α under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function , 2000, Oncogene.

[73]  M. Schindl,et al.  Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. , 2000, Cancer research.

[74]  J. M. Arbeit,et al.  Hypoxia-inducible Factor-1α Is a Positive Factor in Solid Tumor Growth , 2000 .

[75]  D. Faller,et al.  Hypoxia affects tumor cell invasiveness in vitro: the role of hypoxia-activated ligand HAL1/13 (Ku86 autoantigen). , 2000, Cancer letters.

[76]  G. Semenza,et al.  Expression of hypoxia‐inducible factor 1α in brain tumors , 2000 .

[77]  A. Koong,et al.  Loss of PTEN facilitates HIF-1-mediated gene expression. , 2000, Genes & development.

[78]  G. Semenza,et al.  Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. , 2000, Genes & development.

[79]  G. Semenza,et al.  Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2. , 1999, Cancer research.

[80]  C. Wykoff,et al.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis , 1999, Nature.

[81]  M. Gassmann,et al.  Up-regulation of hypoxia-inducible factor-1alpha is not sufficient for hypoxic/anoxic p53 induction. , 1998, Cancer research.

[82]  N. Osheroff,et al.  Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme. , 1998, Biochimica et biophysica acta.

[83]  Jessica Lo,et al.  HIF‐1α is required for solid tumor formation and embryonic vascularization , 1998 .

[84]  J. Brown,et al.  Exploiting tumour hypoxia and overcoming mutant p53 with tirapazamine. , 1998, British Journal of Cancer.

[85]  G. Semenza,et al.  V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression. , 1997, Cancer research.

[86]  L. H. Gray,et al.  The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. , 1953, The British journal of radiology.

[87]  H. Shim Hypoxia-Inducible Factor-1 , 2015 .